| HOME >> BIOLOGY >> TECHNOLOGY |
Cautionary Statement
This press release contains forward-looking statements concerning the
Company's business and products. The Company's actual results may differ
materially depending on a number of risk factors including, but not limited
to, the following: general economic and business conditions, obtaining
regulatory approval for new products, the expected contribution of higher
margin products, government support for rural health care, competition from
existing and new competitors, changes in technology, and various other
factors beyond its control. All forward-looking statements are expressly
qualified in their entirety by this Cautionary Statement and the risk
factors detailed in the Company's reports filed with the Securities and
Exchange Commission. China Medicine Corporation undertakes no duty to
revise or update any forward- looking statement to reflect events or
circumstances after the date of this release.
CHINA MEDICINE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME AND OTHER COMPREHENSIVE INCOME
FOR THREE MONTHS ENDED MARCH 31, 2008 AND 2007
(Unaudited)
2008 2007
REVENUES
Product sales $6,851,384 $4,883,209
Medical formula sales 209,655 209,786
Total revenues 7,061,039 5,092,995
COST OF GOOD SOLD 4,749,019 3,405,417
| SOURCE China Medicine Corporation Copyright©2008 PR Newswire. All rights reserved |